Careers  |  Sign In  |  Register  |   Twitter

Latest in Pain Management

An article in The New York Times reports the FDA said “it would not approve generic versions of the powerful narcotic OxyContin, the painkiller that symbolized a decade-long epidemic of prescription drug abuse.” The original version of the drug “could be easily crushed, a step that released its entire...
A new article in the Los Angeles Times' Booster Shots blog reports researchers "have succeeded in using functional magnetic resonance imaging to tease apart the brain's consistent response to physical pain from its very similar response to emotional pain." The study differentiated the responses to the pain...
Painful chemotherapy-induced neuropathy is currently not treatable, prompting a new study in The Journal of the American Medical Association “to determine the effect of duloxetine, 60 mg daily, on average pain severity.” Patients were randomly assigned to receive duloxetine followed by placebo or placebo...